Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc. C.COOL

Alternate Symbol(s):  CLABF

Healthcare Cannabis
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. The Company, through its wholly owned subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics.


CSE:COOL - Post by User

Core One Labs Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(29)
•••
Post by bullman246on Oct 14, 2021 4:34pm
220 Views
Post# 34006870

Nasdaq Listing Approval Status

Nasdaq Listing Approval StatusSo how's that NASDAQ listing approval going? It's been at least 2-3 months now.

With this stock scam dropping in price for the last 3 months, and now trading at an all time low (lower than it started at, 10 years ago), Nasdaq approval seems highly unlikely.

I guess that's why you don't hear anything from the scammers, running this stock scam. Same B/S with the Cannastrips patent that never happened.

Nothing this company ever promises, ever comes true. All investors ever get, is lies, broken promises, and B/S, to draw in more suckers.

At least investors/suckers are finally seeing what a stock scam this is. Just look at the 10 yr graph. Who in their right mind, would invest in such crooked/incompetent management?

COOL - Such a pathetic POS!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities